Giant Cell Lesions of the Craniofacial Bones
Open Access
- 20 November 2014
- journal article
- review article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 8 (4) , 445-453
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The role of SH3BP2 in the pathophysiology of cherubismOrphanet Journal of Rare Diseases, 2012
- Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of CherubismCell, 2011
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursThe Journal of Pathology, 2011
- Noonan syndrome and clinically related disordersBest Practice & Research Clinical Endocrinology & Metabolism, 2011
- Noonan Syndrome: Clinical Aspects and Molecular PathogenesisMolecular Syndromology, 2010
- Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndromeEuropean Journal of Human Genetics, 2008
- Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jawBritish Journal of Oral and Maxillofacial Surgery, 2008
- Neurofibromatosis presenting with a cherubism phenotypeEuropean Journal of Pediatrics, 2006
- Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndromeJournal of Medical Genetics, 2005
- A case of neurofibromatosis-Noonan syndrome with a central giant cell granulomaOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2004